Trending Now
Business
Syracuse Plans to Punish Clemson’s Trevor Lawrence
Clemson has an embarrassment of riches. The Tigers won the National Championship two years ago with DeShaun Watson, Jordan Leggett and others, knocking off...
DeSean Jackson’s Car Found Abandoned With Marijuana, Hollow Point Bullets Inside
Tampa Bay Buccaneers wide receiver DeSean Jackson's car was found wrecked and abandoned on Christmas Eve. What was contained in the car could become...
Lifestyle today
Entertainment
Endo: TRT Liability Settlement Clears Path For Explosive Growth
Endo Pharmaceuticals (OTCPK:ENDO) recently announced it has executed a master settlement agreement allowing for the resolution of all the company's known testosterone replacement therapy...
FBI Wiretap Shows Sean Miller Discussed $100K Payment To Deandre Ayton
College basketball has dominated the news cycle over the past six months and has not been for anything positive. Former Louisville basketball coach Rick...
Week 24: Financial Times, Martin Sandbu Deny Blacks Predicted The Financial Crisis
The global economy is still reeling from the Financial Crisis of 2008. The Crisis came out of nowhere and many economists never saw it...
Purdue Pharma Settlement Could Impact Other Opioid Trials
Former president Donald Trump was highly critical of opioid drug manufacturers. He wanted to shed more light on their role in the...
Washington AG Bob Ferguson Tweaking So Hard, BMF’s Lamar Is Taking Pictures
President Trump threw down the gauntlet in 2017, promising to bring opioid manufacturers to justice for their role in the opioid epidemic....
Urban Outfitters Is Running In Quicksand
The holiday shopping season was kind to retailers, and I expected stellar results. Revenue from Target (TGT) and Abercrombie & Fitch (ANF) both grew...
Spike Lee Trump Rant: ‘That Motherf*cker Did Not Denounce The Klan’
Spike Lee's career as a film maker has lasted for three decades. In the '80s and '90s He spoke for a generation of African...
Blavatnik’s $3 Billion Stake Could Intensify Teva’s Hemorrhaging
Teva (TEVA) has been reeling from a $40 billion acquisition of Allergan's (AGN) generics business in 2015 that has since gone awry. Generic drugs...
























































































































